Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
1.69 USD +1.81% Intraday chart for Inhibikase Therapeutics, Inc. -8.15% +33.07%
Jun. 05 Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline CI
May. 21 HC Wainwright Adjusts Inhibikase Therapeutics Price Target to $23 From $27, Maintains Buy Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
INHIBIKASE THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+1.81%-8.15%+33.07%-59.76% - 12.15M
Bullish
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. Relative Strength Chart